• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

停用聚多卡醇硫酸酯钠后双侧卵黄样沉着物迅速消退的罕见病例。

An unusual case of rapid resolution of bilateral vitelliform deposits after discontinuation of pentosan polysulfate sodium.

作者信息

Kalaw Fritz Gerald P, Scott Nathan L, Borooah Shyamanga

机构信息

Jacobs Retina Center, University of California San Diego, La Jolla, CA, 92093, USA.

Viterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, CA, 92093, USA.

出版信息

Am J Ophthalmol Case Rep. 2023 Jun 20;32:101875. doi: 10.1016/j.ajoc.2023.101875. eCollection 2023 Dec.

DOI:10.1016/j.ajoc.2023.101875
PMID:37645698
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10461119/
Abstract

PURPOSE

To report the structural and functional changes in a 67-year-old male with pentosan polysulfate sodium (PPS) maculopathy with a progressive resolution of bilateral vitelliform lesions after PPS cessation.

OBSERVATIONS

The patient was initially seen after taking daily PPS for over 26 years. Three months after discontinuing PPS, the bilateral vitelliform lesions identified on spectral-domain optical coherence tomography (SD-OCT) at initial consultation had completely resolved. Bilateral resolution of vitelliform lesions was associated with a decline in best-corrected visual acuity, and ellipsoid zone disruption on SD-OCT.

CONCLUSIONS AND IMPORTANCE

Several PPS maculopathy phenotypes have been previously described including vitelliform lesions. Our case highlights that discontinuing PPS may lead to rapid resolution of vitelliform lesions in PPS maculopathy and may be associated with a rapid reduction in vision.

摘要

目的

报告一名67岁男性戊聚糖多硫酸钠(PPS)黄斑病变患者的结构和功能变化,该患者在停用PPS后双侧卵黄样病变逐渐消退。

观察结果

该患者在每日服用PPS超过26年后首次就诊。停用PPS三个月后,初诊时通过光谱域光学相干断层扫描(SD-OCT)发现的双侧卵黄样病变已完全消退。卵黄样病变的双侧消退与最佳矫正视力下降以及SD-OCT上的椭圆体带破坏有关。

结论与意义

先前已描述了几种PPS黄斑病变表型,包括卵黄样病变。我们的病例强调,停用PPS可能会使PPS黄斑病变中的卵黄样病变迅速消退,并可能与视力迅速下降有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d61f/10461119/e1ed07b665f3/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d61f/10461119/6c9d31b1c539/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d61f/10461119/e1ed07b665f3/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d61f/10461119/6c9d31b1c539/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d61f/10461119/e1ed07b665f3/gr2.jpg

相似文献

1
An unusual case of rapid resolution of bilateral vitelliform deposits after discontinuation of pentosan polysulfate sodium.停用聚多卡醇硫酸酯钠后双侧卵黄样沉着物迅速消退的罕见病例。
Am J Ophthalmol Case Rep. 2023 Jun 20;32:101875. doi: 10.1016/j.ajoc.2023.101875. eCollection 2023 Dec.
2
Disease Course in Patients With Pentosan Polysulfate Sodium-Associated Maculopathy After Drug Cessation.戊聚糖多硫酸钠相关性黄斑病变患者停药后的疾病进程。
JAMA Ophthalmol. 2020 Aug 1;138(8):894-900. doi: 10.1001/jamaophthalmol.2020.2349.
3
Type 3 macular neovascularization in a patient with pentosan polysulfate maculopathy.患有戊聚糖多硫酸酯黄斑病变患者的3型黄斑新生血管形成。
Am J Ophthalmol Case Rep. 2022 Dec 5;29:101771. doi: 10.1016/j.ajoc.2022.101771. eCollection 2023 Mar.
4
NINE-YEAR PROGRESSION OF PENTOSAN MACULOPATHY WITH MULTIMODAL RETINAL IMAGING.九年内窥镜下评估五倍子治疗黄斑病变的进展。
Retin Cases Brief Rep. 2023 Nov 1;17(6):664-667. doi: 10.1097/ICB.0000000000001276.
5
Cystoid Macular Edema Arising 10 Years After Cessation of Pentosan Polysulfate Sodium Successfully Treated With Bevacizumab.停用戊聚糖多硫酸钠10年后出现的黄斑囊样水肿经贝伐单抗成功治疗
J Vitreoretin Dis. 2022 Nov 18;7(1):83-86. doi: 10.1177/24741264221136907. eCollection 2023 Jan-Feb.
6
Pigmentary Maculopathy Associated with Chronic Exposure to Pentosan Polysulfate Sodium.色素性视网膜炎与慢性戊聚糖多硫酸钠暴露相关。
Ophthalmology. 2018 Nov;125(11):1793-1802. doi: 10.1016/j.ophtha.2018.04.026. Epub 2018 May 22.
7
Case Report: Pentosan Polysulfate Sodium Maculopathy Originally Diagnosed as Pattern Macular Dystrophy.病例报告:最初诊断为模式型黄斑营养不良的聚戊烯硫酸钠黄斑病变。
Optom Vis Sci. 2021 Jun 1;98(6):552-556. doi: 10.1097/OPX.0000000000001702.
8
Two-Year Outcomes After Variable Duration of Drug Cessation in Patients With Maculopathy Associated With Pentosan Polysulfate Use.与戊聚糖多硫酸酯治疗相关的黄斑病变患者药物戒断时间不同的两年结局。
JAMA Ophthalmol. 2023 Mar 1;141(3):260-266. doi: 10.1001/jamaophthalmol.2022.6093.
9
VISUAL AND ANATOMICAL CHANGES AFTER DRUG CESSATION IN PENTOSAN POLYSULFATE SODIUM-ASSOCIATED MACULOPATHY.戊聚糖多硫酸钠相关黄斑病变停药后的视力和解剖变化。
Retin Cases Brief Rep. 2023 Sep 1;17(5):507-510. doi: 10.1097/ICB.0000000000001242.
10
SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY FEATURES IN DIFFERENT STAGES OF BEST VITELLIFORM MACULAR DYSTROPHY.不同阶段最佳型类湿性年龄相关性黄斑变性的光谱域光相干断层成像特征。
Retina. 2018 May;38(5):1041-1046. doi: 10.1097/IAE.0000000000001634.

引用本文的文献

1
Advanced pentosan polysulfate sodium maculopathy with low cumulative exposure and hydroxychloroquine use.低累积暴露量及使用羟氯喹导致的晚期戊聚糖多硫酸酯钠黄斑病变
Am J Ophthalmol Case Rep. 2024 Nov 22;36:102224. doi: 10.1016/j.ajoc.2024.102224. eCollection 2024 Dec.

本文引用的文献

1
Multimodal imaging in Best Vitelliform Macular Dystrophy: Literature review and novel insights.Best 型卵黄样黄斑部营养不良的多模态影像:文献回顾与新见解。
Eur J Ophthalmol. 2024 Jan;34(1):39-51. doi: 10.1177/11206721231166434. Epub 2023 Mar 27.
2
Vitelliform maculopathy: Diverse etiologies originating from one common pathway.玻璃膜疣病变:源自同一共同途径的多种病因。
Surv Ophthalmol. 2023 May-Jun;68(3):361-379. doi: 10.1016/j.survophthal.2023.01.009. Epub 2023 Jan 30.
3
Clinical Correlation Between Optical Coherence Tomography Biomarkers and Retinal Sensitivity in Best Vitelliform Macular Dystrophy.
最佳型类卵黄斑营养不良的光学相干断层扫描生物标志物与视网膜敏感性的临床相关性。
Transl Vis Sci Technol. 2022 Sep 1;11(9):24. doi: 10.1167/tvst.11.9.24.
4
Histology and Clinical Lifecycle of Acquired Vitelliform Lesion, a Pathway to Advanced Age-Related Macular Degeneration.获得性类玻璃膜病变的组织病理学和临床生命周期,通向晚期年龄相关性黄斑变性。
Am J Ophthalmol. 2022 Aug;240:99-114. doi: 10.1016/j.ajo.2022.02.006. Epub 2022 Feb 19.
5
Expanded Clinical Spectrum of Pentosan Polysulfate Maculopathy: A Macula Society Collaborative Study.戊聚糖多硫酸酯黄斑病变的临床谱扩展:黄斑学会合作研究
Ophthalmol Retina. 2022 Mar;6(3):219-227. doi: 10.1016/j.oret.2021.07.004. Epub 2021 Jul 21.
6
Pentosan Polysulfate Maculopathy: Prevalence, Spectrum of Disease, and Choroidal Imaging Analysis Based on Prospective Screening.聚戊烯多硫酸酯斑病变:基于前瞻性筛查的患病率、疾病谱和脉络膜成像分析。
Am J Ophthalmol. 2021 Jul;227:125-138. doi: 10.1016/j.ajo.2021.02.025. Epub 2021 Feb 27.
7
Large Subfoveal Vitelliform Lesions in a Case of Pentosan Polysulfate Maculopathy.戊聚糖多硫酸酯黄斑病变一例中的大黄斑中心凹下卵黄样病变
Ophthalmology. 2020 Dec;127(12):1641. doi: 10.1016/j.ophtha.2020.07.048.
8
Disease Course in Patients With Pentosan Polysulfate Sodium-Associated Maculopathy After Drug Cessation.戊聚糖多硫酸钠相关性黄斑病变患者停药后的疾病进程。
JAMA Ophthalmol. 2020 Aug 1;138(8):894-900. doi: 10.1001/jamaophthalmol.2020.2349.
9
Pentosan-associated maculopathy: prevalence, screening guidelines, and spectrum of findings based on prospective multimodal analysis.五碳糖相关的黄斑病变:基于前瞻性多模态分析的患病率、筛查指南和病变特征。
Can J Ophthalmol. 2020 Apr;55(2):116-125. doi: 10.1016/j.jcjo.2019.12.001. Epub 2020 Jan 20.
10
Progressive Maculopathy After Discontinuation of Pentosan Polysulfate Sodium.停用戊聚糖多硫酸钠后的进行性黄斑病变
Ophthalmic Surg Lasers Imaging Retina. 2019 Oct 1;50(10):656-659. doi: 10.3928/23258160-20191009-10.